Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Radnor, PA – January 12, 2025 (NEWMEDIAWIRE) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) has announced that Kyverna Therapeutics, Inc. (Kyverna) is notifying investors that a securities class action lawsuit has been filed against it. (NASDAQ: KYTX) may purchase and/or represent Kyverna common stock prior to Kyvernas’ initial public offering (IPO) on February 8, 2024. The lead plaintiff deadline is February 7, 2025.
Contact and verify Kessler Topaz Melzer, LLP:
If you have a Kyverna bankruptcy, click here or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
Also attorney Jonathan Nagy, Esq. Call (484) 270-1453 or email info@ktmc.com.
Accused of misconduct:
The complaint alleges that in the prospectus and registration statements issued in connection with the IPO, defendants made materially false and/or misleading statements and/or omissions regarding the company’s business, operations and prospects. Specifically, the defendants made false and/or misleading statements, and/or failed to disclose, that Kyverna had adverse data related to its clinical trials at the time of its IPO.
Lead Plaintiff Procedure:
After February 7, 2025, Kyverna Investors may choose to appoint Kessler Topaz Meltzer & Check, LLP or other counsel as the class’s lead plaintiff representative, or choose to do nothing and remain a member of the absent class. A lead plaintiff is the representative party who leads the litigation on behalf of all class members. The lead plaintiff is usually the investor or a small group of investors who have the largest financial interest and who are also sufficient and common to the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class, and these attorneys are either lead or class counsel if approved by the court. Your ability to participate in any recovery will not affect the decision to serve as lead plaintiff or not.
Kessler Topaz Meltzer & Check, LLP encourages Kyverna investors who have suffered significant losses to contact the firm directly for additional information.
Click here to register for the case or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm
About KESSLER Topaz Meltzer & Czech, LLP:
Kessler Topaz Meltzer & Check, LLP litigates class actions in state and federal courts across the country and around the world. The company has developed an international reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, defamation, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.
Contact:
Kessler Topaz Meltzer & Check, LLP
Jonathan Nagy, Esq.
(484) 270-1453
280 King of Prussia road
Radnor, PA 19087
info@ktmc.com
It may be considered an attorney advertisement in certain jurisdictions. Past results do not guarantee future results.
Copyright 2025 JCN Newswire All rights reserved.
